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A B S T R A C T   
In twin/multiple pregnancy, siblings experience an adverse intrauterine environment which forms the major 
etiological factor leading to pathological conditions. The status of the developing fetus is highly determined by 
the nitric oxide (NO) level, that facilitates vasodilation which in turn modulates the oxygen and nutrition supply. 
As the umbilical cord (UC) lacks innervation, activation of the endothelial nitric oxide synthase (NOS3) is 
fundamental to maintain adequate NO production. Recent ground breaking fact showed that under stress con-
ditions, circulating red blood cells (RBCs) can actively produces NO as a “rescue mechanism”. Therefore, this 
study majorly focused on the molecular mechanisms that affected the redox environment by altering NOS3 
activation - both in the UC arteries and vein endothelium and RBCs - that have impacts on developmental pa-
rameters, like birth weight. In connection to that, we pursued the communication efficiency between the vessels' 
endothelium and the circulating RBCs in demand of bioavailable NO. Our results indicated that twinning itself at 
stage 33–35 weeks, does not reduce the NOS3 level and its phosphorylation status in the cord vessels. However, 
RBC-NOS3 activation is highly upregulated during this period - providing additional evidence for the active 
regulatory role of fetal RBCs in the rate of blood flow - and this functional activity highly correlates with the birth 
weight of the fetuses. Detailed analysis on NOS3 signalling at different time points of gestation could establish a 
benchmark in understanding of the pathophysiological mechanisms involved in the process of developing 
neonatal vascular diseases.   
1. Introduction 
The physiological state of pregnancy is always in demand for excess 
oxygen supply which can easily disrupt the feto-maternal redox ho-
meostasis balance. In connection to that, there are increasing evidences 
of enhanced oxidative insult conditions, like preeclampsia, ectopic 
pregnancy, placental abruption and so on. Moreover, in cases of multi-
ple/twin pregnancy, additional trauma exists with greater risks of 
spontaneous miscarriage, preterm delivery, gestational hypertensive 
disorders, intrauterine growth restriction, perinatal death and related 
postnatal and neonatal illnesses. Modern usage of in-vitro fertilization 
(IVF) therapies has led to higher incidence of multiple pregnancies. 
There have been relevant epidemiological data on the increasing fetal, 
neonatal and perinatal mortality rate of 3–6 times in twin and 5–15 
times in other multiple pregnancies with comparison to singleton de-
liveries [1]. The mechanism in twinning depends on zygosity; twins can 
either develop from one zygote (monozygotic) or from two separate 
zygotes (dizygotic). Monozygotic twins make up approximately 30% of 
twin pregnancies [2,3]. In general, ~16% of twin gestations have 
discordance i.e. difference in the weights of siblings higher than 15–25% 
[4]. As per the American College of Obstetricians and Gynaecologists 
(ACOG) discordant growth gets associated with anomalies like, intra-
uterine growth restriction, preterm birth, infection of one of the fetus, 
stillbirth, umbilical arterial pH <7.1, respiratory distress, and death 
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within 1 week of birth [5]. 
Fetal homeostatic condition and the intrauterine environment criti-
cally depend on the efficiency of the feto-placental circulation. The UC 
vascular system is the sole pathway of oxygen and nutrient transport to 
the fetus through the placenta. The UC circulation system is usually 
made up of one vein and two arteries. From the placenta, the oxygenated 
blood and nutrition are transported by the vein to the fetus and arteries 
carry the deoxygenated blood back to the placenta. In this scenario, it is 
clear that the UC vein is primarily and directly exposed to the toxic 
materials/free radicals unfiltered by or generated in the placenta. Any 
alteration in it may serve as fingerprints of the damages affecting the 
in–utero development. Major complications in fetal development can be 
directly or indirectly connected to the umbilical cord disorders causing 
intrauterine hypoxia and/or impaired blood flow to the developing 
fetus. 
The major part of the umbilical cord lacks innervation and hence the 
vascular tone mainly depends on the level of NO, i.e. synthesized by the 
NOS3 [6]. The NO, being a potent vasoactive agent, causes vasodilation 
and increases the rate of oxygen perfusion and nutrient supply [7]. Any 
kind of impaired response and loss in the bioactivity of endothelium- 
derived NO within the umbilical cord vascular system causes intra-
uterine hypoxia, increased feto-placental vascular resistance, and 
retardation in the fetal growth [8,9]. NOS3 activation gets regulated by 
its substrate L-arginine concentration, availability of cofactors, rate of 
electron transfers, subcellular localization, post-translational modifica-
tions and diverse interacting proteins [10,11]. The process of NOS3 
coupling/dimerization is the most crucial step towards its activation; 
low concentration of L-arginine substrate causes NOS3 uncoupling and 
dysfunctionality [12,13]. NOS3 is in direct competition with Arginases 
for their common substrate, therefore an increased expression of Argi-
nases indirectly influences the NOS3 activation process [14,15]. Among 
the post-translational modification steps, phosphorylation of NOS3 
specific at Ser1177 residue is the prime site for the enzyme activation 
whereas the Thr495 residue be the negative regulatory site. Under shear 
stress conditions the phosphorylation step gets induced in the cells due 
to key factors like vascular endothelial growth factor and increased 
influx of electrons through the reductase domain from NADPH to the 
haem group in the oxygenase domain [16,17]. 
Under severe oxidative stress conditions, influenced by any intrinsic 
or extrinsic pathophysiological factors, there are obvious production of 
reactive oxygen species (ROS)/strong oxidants; like superoxide anion 
(O2•− ), hydrogen peroxide (H2O2) and hydroxyl radical. The O2•− , in 
elevated level, undergoes spontaneous reactions and readily scavenges 
the bioavailable NO in the vascular system by forming deleterious pro- 
oxidant entity peroxynitrite (ONOO− ) [18–20]. One of the pivotal fac-
tor in the development of endothelial dysfunction (ED) is the reduced 
production/bioavailability of NO, resulting in an impaired endothelial 
growth and vasodilation. 
RBCs were mainly ascribed as carriers for transmitting oxygen and 
NO into the vascular bed, recently emerged with a ground breaking 
publication showing the evidence for a NO synthase protein within the 
red blood cells (RBC-NOS3) [21,22]. Supposedly, the occurrence of ED 
can be sensed by the circulating RBCs, and thereby under acute shear 
stress conditions NO bioavailability might be increased by the RBC- 
NOS3 activation pathway. As the UC endothelium directly comes in 
contact with all the blood components and most predominantly the 
circulating red blood cells (RBCs), it intends to establish an effective 
crosstalk mechanism between them. 
In our earlier work, we demonstrated that RBCs originated from twin 
neonates exhibit quite a high oxidative stress condition with the accu-
mulation of NO3− /NO2− and strong oxidant molecules (H2O2 and 
ONOO− ), compared to samples originated from the single pregnancy 
[23]. The developmental status of neonates is determined by a number 
of multifactorial and complex processes, particularly involving the sig-
nalling pathway of NOS3 activation, which significantly determines the 
bioavailable NO level, and facilitates vasodilation which ultimately 
modulate oxygen and nutrition supply for the developing fetus. In our 
recent work, we exhibited that during twin pregnancy, both the UC 
vessels and the RBCs of mature fetuses are impaired in their NOS3-NO 
producing capacity [24]. Here, we further pursued and examined the 
molecular consequences due to oxidative stress in neonates born from 
preterm twin pregnancies and attempted to establish a possible link 
between a certain alteration in the NOS3-NO pathway and the neonatal 
birth weight. We followed the status of premature twins with 3 different 
birth weight groups. In the appropriate weight for age category, samples 
of siblings born with low and high weight were compared to their age 
and weight matched neonates, from single pregnancy. Additionally, we 
also compared the samples that originated from the preterm discordant 
siblings. 
2. Materials and methods 
2.1. Human samples 
According to the Declaration of Helsinki, informed consent was 
requested from pregnant women to collect a small portion of the um-
bilical cord along with fetal cord blood samples. The study protocol was 
approved by the Ethics Committee from the Department of Obstetrics 
and Gynaecology at the University of Szeged, Hungary (16/2014). The 
study protocol strictly followed several exclusion criteria to collect the 
clinical samples such as (i) maternal age below 18 years, (ii) gestational 
diabetes, obesity, infection and inflammatory conditions or disorders 
such as cardiovascular diseases, (iii) complications or difficulty during 
delivery, (iv) dizygotic twin birth (v) fetal distress, (vi) malformations or 
evidence of genetic disorders and (vii) neonates born from mothers 
addicted to alcohol and /or smoking habit. The nutritional status of the 
mothers during pregnancy was satisfactory; no case of malnutrition 
occurred. 
Clinical samples were grouped under different inclusion criteria. In 
the first group, 16 pairs of clinical samples from pre-mature, non- 
discordant, monozygotic, dichorionic twins were collected. Neonates 
were categorized based on their maturity and birth weight (percentile 
value); 2430–2570 g/33 + 3–34 + 6 weeks/95th percentile (Premature, 
High birth weight twins - Pr-Hwt) and 1940–1990 g/33–33 + 6 weeks/ 
50th percentile (Premature, Low birth weight twins - Pr-Lwt). As control 
for the Pr-Hwt group, 15 samples of age and weight matched 
2200–2500 g/33–35 weeks/95th percentile singletons were collected 
(Pr-Hws). The clinical parameters of the study group and the maternal 
age are presented in the Supplementary as Table S1. 
In the second group, 20 pairs of clinical samples from premature, 
monozygotic, dichorionic, discordant twin category were collected. The 
criteria for discordance was followed as per the guidelines laid down by 
ACOG USA, with a minimum of 25% discordance between the siblings' 
birth weight. Siblings were grouped according to their birth weight; 
2600–2890 g/35–35 + 4 weeks/90–95th percentile in the high weight 
group (Premature, Discordant, High birth weight neonates - PrD-Hwt) 
and 1860–2040 g/35–35 + 4 weeks/10–25th percentile (Premature, 
Discordant, Low birth weight neonates - PrD-Lwt). The clinical param-
eters of the study group and the maternal age are presented in the 
Supplementary as Table S2. 
2.2. Blood smear image processing and data analysis 
Using the validated calculation software MatLab we processed and 
analysed eosin stained blood smear images, originated from each of the 
collected sample groups. Identification of different phenotypic varia-
tions in the RBC populations was conducted with an automated bio-
image analysis tool CellProfiler™ (available on http://cellprofiler.org) 
[25]. 
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2.3. Preparing umbilical cord and arterial cord blood samples for 
immunostaining 
Small dissected portions of the umbilical cord were fixed with 4% 
(w/v) paraformaldehyde in 0.05 M phosphate buffer pH 7.4 (PB) and 
cryopreserved with 30% (w/v) sucrose in PB with addition of 0.1% (w/ 
v) Na-azide. Specimen samples were embedded in Tissue-Tek® O.C.T.™ 
(Sakura Europe 4583, Alphen aan den Rijn, Netherlands) and cryosec-
tioned with slice thickness of 16 μm. Further it gets mounted on 
Superfrost™ ultra plus® (Thermo scientific J3800AMNZ, Massachu-
setts, United States) microscope slides and kept on − 80 ◦C till further 
processing [26]. 
Whole blood, derived from the cord arteries, was subjected to 
centrifuge at 200 ×g for 10 min at 4 ◦C. The lower two-thirds of the RBC 
phase was collected, washed with physiological salt solution (0.9% 
NaCl, w/v) and fixed with 4% (w/v) paraformaldehyde in 0.05 M PB at 
4 ◦C for 1 h and further processed for immunostaining [27]. To test the 
purity of the isolated RBCs, the cells were stained with RBC-specific 
marker anti Glycophorin A, where the purity of the samples was 
>95% for RBCs [28]. 
2.4. Immunolabelling on umbilical cord sections and isolated red blood 
cells 
Umbilical cord sections and fixed RBCs were stained by standard 
protocols [24]. Briefly, samples were permeabilized by 0.1% Triton X- 
100 at room temperature for 20 min. Non-specific antibody binding sites 
were blocked with 4% (w/v) bovine serum albumin and 5% (v/v) 
normal goat serum in PB, and double labelled with primary antibodies 
overnight at 4 ◦C. After the incubation step, samples were washed and 
further incubated with goat anti-mouse Alexa®488/anti-rabbit 
Alexa®647- or goat anti-rabbit Alexa®488/anti-mouse Alexa® 647-con-
jugated secondary antibodies in 1:2000 dilution, for 2 h in dark at room 
temperature (see Supplementary Table S3 for the detailed antibody list). 
Finally, the slides were counterstained with 4′, 6-diamidino-2-phenylin-
dole (D9542 from Sigma-Aldrich, St. Louis, MO, USA) in a final con-
centration of 1 μg/ml, for 5 min in dark, washed, dried and mounted, 
using Antifading, BrightMount/Plus aqueous mounting medium (Abcam 
ab103748, Cambridge, United Kingdom), and examined under epi-
fluorescence microscope (Nikon Eclipse 80i, 100× immersion objective; 
Nikon Zeiss Microscopy GmbH, Jena, Germany) with a QImaging 
RETIGA 4000R camera, using Capture Pro 6.0 software (QImaging, 
Surrey, BC, Canada). Images were processed and analysed using 
ImageJ® software (http://imagej.nih.gov/ij/). 
The stained RBCs, following the secondary antibody incubation step, 
were washed and processed for quantitative analysis (FACS, BD FACS-
Calibur™, BD Biosciences, New Jersey, United States) [28,29]. The 
FACS data were analysed using FlowJo™ (FlowJo™ Software for Win-
dows Version 10, Oregon, United States). 
2.5. Assay and detection for viability in the RBCs 
Fresh arterial cord blood was collected and centrifuged at 200 ×g for 
5 min. From the lower two-thirds of the RBC phase 10 μl was collected 
and diluted by 10× in 0.9% (w/v) physiological salt solution having pH 
7.4. Briefly, 1 μl of the diluted RBCs were mixed with 250 μl of Annexin 
binding buffer and 2.5 μl Annexin V using the Annexin V-FITC 
Apoptosis/Staining Detection kit (Abcam ab14085, Cambridge, United 
Kingdom). The quantitative measurement was done by FACS (FACS, BD 
FACSCalibur™, BD Biosciences, New Jersey, United States) [30] and all 
data were analysed using FlowJo™ (FlowJo™ Software for Windows 
Version 10, Oregon, United States). 
2.6. Statistical analysis 
All statistical analysis was considered with one-way analysis of 
variance (ANOVA) and Newman-Keuls multiple comparison test using 
GraphPad Statistical Software version 6.0. (GraphPad Software, San 
Diego, CA, USA) The level of statistical significance was accepted at *p 
≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and ****p ≤ 0.0001. 
3. Result 
3.1. Expression of endothelial and inducible NOS, and Arginase1 in the 
non-discordant study populations 
In this study, molecular parameters of UC vessels and cord blood, 
originated from twin pairs with high birth weight (95th percentile) were 
compared to age and weight matched singletons and age-matched twin 
pairs born with low birth weight (50th percentile). 
Sections of the UCs originated from non-discordant twin pairs and 
singletons were immunolabelled and subjected to Image J© evaluation. 
In the Hwt versus Hws comparison, a significant increase was 
measured in the NOS3 expression and also in its phosphorylation in-
tensity level, within the Hwt arteries (~13 and ~17% respectively). In 
the vein, both values stayed unaltered (Fig. 1) (Supplementary Figs. S1 
A–F and S2 A–F). 
Considering the Hw versus Lw twin populations, NOS3 expression in 
the Lw arteries to some extent remained behind the Hw values (~28%) 
with about the same phosphorylation intensity level. In the vein, the 
NOS3 expression was unaltered, with a significant increase in the 
phosphorylation intensity (~26%) (Fig. 2) (Supplementary Figs. S1 D–I 
and S2 D–I). As a consequence of it, the phosphorylation status of NOS3 
(NOS3/pNOS3 ratio) in both the vessels of Lwt samples was increased 
compared to the Hwt samples. 
The NOS3 activation is influenced by Arginase1, which competes for 
the common substrate, L-arginine. Arginase1 expression in both the ar-
teries and veins of the Hw twins exhibited significant elevation 
compared to their age and weight-matched singletons, ~85%, and 
~30%, respectively (Fig. 1). In the Lw and Hw twin correlation, there 
was a ~22% increase in Lw arteries while in the veins no significant 
difference was detected (Fig. 2 and Supplementary Figs. S3 A, D, G and 
S4 A, D, G). 
Upregulation of the inducible NOS (NOS2) expression could serve as 
a compensatory mechanism to increase the bioavailable NO level in the 
vascular endothelial layer under shear stress conditions. Comparison of 
the singleton versus Hwt values, there were no significant difference in 
the NOS2 expression for any of the vessels (Fig. 1). In case of Hwt versus 
Lwt comparison, the NOS2 value was significantly higher in the Lwt 
arteries (~47%), while in the vein it stayed unchanged (Fig. 2 and 
Supplementary Figs. S3 B, E, H and S4 B, E, H). 
Following the NOS3 level and its phosphorylation status at position 
Ser1177 by FACS analysis in the isolated arterial RBC population, 
(where in each case according to the blank sample, an arbitrary 
borderline was considered along the x-axis, that divided the total RBC 
population into basal and high intensity levels) the Hwt group showed a 
73.64% higher NOS3 expression and 206.35% higher phosphorylation 
intensity level when compared to their age and weight matched sin-
gletons (Fig. 1). While, there was no significant variation in these values, 
between the Hw and Lw twin neonates (Fig. 2 and Supplementary 
Fig. S5). 
Following the expression of Arginase1 by FACS analysis, clearly 
indicated a 48% elevation in the Hwt values when compared to their 
matched singletons (Fig. 1). Between the twin groups, there was no 
significant difference in Arginase1 expression level (Fig. 2 and Supple-
mentary Fig. S6 A–D). 
3.2. NOS3 expression and activation, NOS2 and Arginase1 level in the 
discordant study populations 
In this part of the study, molecular parameters of twin siblings, born 
with significantly high weight differences, were compared. The high 
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Fig. 1. Estimation of the expression of NOS3 and 
phosphorylated NOS3, NOS2, Arginase1 and 4-HNE 
level in the UC vascular endothelium and fetal RBCs 
of the high weight preterm twin neonates. Measure-
ment of the mean fluorescence intensity (MFI) were 
expressed in percentage of NOS3 and its activated 
level i.e. phosphorylated NOS3 (pNOS3), NOS2, 
Arginase1 and 4-HNE level of the preterm non- 
discordant high birth weight twin neonates in com-
parison to their age and weight matched singletons 
taken as control. The red dotted line represents the 
control intensity level at 100%. The significant dif-
ferences were accepted at **p < 0.01, ***p < 0.001 
and ****p < 0.0001 based on one-way ANOVA using 
the Newman-Keuls multiple comparison test.   
Fig. 2. Quantification of the expression of NOS3 and 
phosphorylated NOS3, NOS2, Arginase1 and 4-HNE 
level in the UC vascular endothelium and fetal RBCs 
of the low weight preterm twin neonates. Measure-
ment of the MFI were expressed in percentage of 
NOS3, phosphorylated NOS3, NOS2, Arginase1 and 
4-HNE level of the preterm non-discordant low birth 
weight twin neonates in comparison to their high 
weight twin group taken as control. The red dotted 
line represents the control intensity level at 100%. 
The significant differences were accepted at ***p <
0.001 and ****p < 0.0001 based on one-way ANOVA 
using the Newman-Keuls multiple comparison test.   
Fig. 3. Estimation of the expression of NOS3 and 
activated pNOS3, NOS2, Arginase1 and 4-HNE level 
in the UC vascular endothelium and fetal RBCs be-
tween the premature discordant twin pair. Measure-
ment of the MFI were expressed in percentage of 
NOS3, phosphorylated NOS3, NOS2, Arginase1 and 
4-HNE level of the preterm discordant low birth 
weight twin neonates in comparison to their high 
weight twin pair, considered as control. The red 
dotted line represents the control intensity level at 
100%. Statistical significances were accepted at *p <
0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 
based on one-way ANOVA using the Newman-Keuls 
multiple comparison test.   
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weight neonates belonged to the 90–95, and their siblings into the 10–25 
percentile categories. 
In a similar manner, umbilical cord sections were double-labelled, 
first for NOS3/pNOS3, and subjected to Image J© evaluation. The 
NOS3 and pNOS3 intensities were significantly lower in both UC vessels 
of the low weight neonates, compared to their high weight siblings; by 
~37% (NOS3) and ~45% (pNOS3) in the artery and by ~19% (NOS3) 
and ~26% (pNOS3) in the vein. The phosphorylation status of NOS3 
(ratio NOS3/pNOS3) were reduced in both the vessel of the Lw-siblings 
(Fig. 3 and Supplementary Figs. S7 and S8). 
Arginase1, being a key player in the NOS3 regulation, was expressed 
at a significantly lowered level in both the vessels (by ~17–18%) of the 
low weight siblings (Fig. 3 and Supplementary Figs. S9 A, D and S10 A, 
D). 
NOS2, serving as an alternative source for bioavailable NO, was 
present at a significantly higher level in the cord arterial endothelium of 
the low weight siblings (by ~24%) while in the vein, a significantly 
lower level (by ~37%) was detected (Fig. 3 and Supplementary Figs. S9 
B, E and S10 B, E). 
In a parallel study, isolated cord arterial RBCs were immunostained 
and analysed by FACS. No significant difference was found in the NOS3 
expression, and also in the frequency of the high NOS3 expressing cells 
between the siblings. However, the pNOS3 intensity level was signifi-
cantly higher in the low weight neonates (by ~29%), consequently, the 
phosphorylated status of NOS3 was significantly higher in these cases 
(Fig. 3 and Supplementary Fig. S11). The Arginase1 expression was 
significantly higher (by ~33%) in the low weight group, due to a 
significantly higher frequency (by ~8–10%) of the high Arginase1 
expressing cells (Fig. 3 and Supplementary Fig. S12 A–C). 
3.3. Quantitative measurement of lipid peroxidation, marked with 4- 
hydroxynonenal and Annexin V positive population 
The most common products of lipid peroxidation, due to excessive 
ROS production, are the oxygenated α, β-unsaturated aldehydes such as 
4-hydroxynonenal (4-HNE). The formation of this aldehyde was fol-
lowed by immunolabelling the aldehyde-protein adduct with anti-4- 
HNE antibody. Furthermore, due to excess rate of lipid peroxidation, 
the level of phosphatidylserine gets altered in the outer leaflet of RBC 
plasma membranes which gets easily detected by Annexin V and 
quantified using FACS analysis. 
3.3.1. Premature non-discordant study population 
The intensity levels of 4-HNE evaluated by Image J©, showed a 
significant increase (by 31%) in the arteries, and stayed unchanged, in 
the vein of the Hw twin neonates, compared to their matched singletons 
(Fig. 1). In the Hwt versus Lwt comparison, there was a significant 17% 
increase in the arteries, while there was no alteration between these 
values in the veins (Fig. 2 and Supplementary Figs. S3 C, F, I and S4 C, F, 
I). 
The 4-HNE intensity level was followed by FACS analysis in the 
isolated RBCs. The Hwt samples, compared to their matched singletons, 
showed a ~108% increase in the 4-HNE intensity level (Fig. 1). RBCs 
originated from the Lwt samples, exhibited 71% increase in comparison 
to the Hwt populations (Fig. 2 and Supplementary Fig. S6 E–H). 
Simultaneously, RBC populations were tested for Annexin V posi-
tivity by FACS analysis. These measurements revealed an increased 
frequency (~12.5%) in the Annexin-V positive RBCs originated from 
Hwt compared to Hws populations. However there was no significant 
difference between the Hwt and Lwt populations (Fig. 4 A–E). 
3.3.2. Premature discordant study population 
Measuring the 4-HNE intensity level, the Lw twins showed a signif-
icant increase in both the artery and vein by 42% and 25% respectively 
(Fig. 3 and Supplementary Figs. S9 C, F and S10 C, F). 
FACS analysis of HNE intensity in the isolated RBCs revealed a 69% 
increase in the Lwt population in comparison to the Hwt group (Fig. 3 
and Supplementary Fig. S12 D–F). 
Furthermore, RBC marked by Annexin V showed a significant in-
crease in the frequency of Annexin V positive cells by ~10% in the Lwt 
cell population compared to those of Hwt origin (Fig. 5 A–C). 
3.4. Analysis of RBC morphological variants 
Increased frequency of morphological variants in the RBC pop-
ulations can be kind of an indication for certain pathological conditions. 
Altogether, we screened over 3000 RBCs from the singletons, ~2000 
from the mature and 4000 from the premature twin populations, and 
looked for Burr cells, Elliptocytes, and Rouleaux formation, among the 
regular, biconcave shaped RBCs. Between the mature and premature 
singleton groups, there was no major significant difference in the fre-
quency of the phenotypical variants. However, a significant difference 
was found between singleton and twin neonates; such as in the mature 
twin RBCs, there was a 3-fold, while in the premature group a 2-fold 
increase occurred in the Burr cell populations. The Elliptocyte and 
Rouleaux variants were virtually absent in the singletons. In relation to 
the mature versus premature twins there was a 2–2.5 fold increase in the 
Elliptocytes and a 5–fold increase in the Rouleaux phenotypes in the 
premature populations, irrespective of their birth weight (Fig. 6). 
4. Discussion 
Twin siblings, in comparison to the age and weight-matched healthy 
singletons, undoubtedly experience an enhanced intrauterine hypoxic 
state with advanced oxidative stress [31–33], that gets directly or 
indirectly associated with umbilical cord disorders and contributes to 
the occurrence of pathological conditions in post-natal or adult life 
[34,35]. Such condition necessitates an efficient cross-talk between the 
vascular endothelium and the circulating RBCs that can enhance vaso-
dilation and improve the rate of blood flow to the fetuses. Therefore, in 
this study we majorly focused on molecular mechanisms that affect the 
redox environment by altering NOS3 activation - both in the UC endo-
thelial layer and RBCs - that have impact on the developmental pa-
rameters. Our result highlighted, that a) twinning itself, does not disturb 
the NOS3 level and its phosphorylation at Ser1177 position in the cord 
vessels. Moreover, in case of twin neonates born with 95th percentile 
value, NOS3 expression and its activation was comparable to the age and 
weight-matched singletons. b) Further, in twins with a lower percentile 
value (50th and 25th), the NOS3 expression lagged behind in the arterial 
cord endothelium, but its phosphorylation at position Ser1177 increased 
in both the cord arteries and in the circulating arterial RBCs. c) Ana-
lysing the discordant twin pairs, it seems, that in the lower weight sib-
lings, the vascular NOS3 system is markedly impaired. d) Finally, we 
also pointed out in this study, that although a significant part of the RBC 
population seems to be functionally active, an increased appearance of 
phenotypic variants indicates the extent of damage in the plasma 
membrane structure and most likely also in its functional activity. 
During twin pregnancy, most likely even the highest NOS3-NO 
production capacity of the UC vessels could not suffice to maintain the 
desired NO levels. The concept for an increased demand for NO under 
highly hypoxic conditions might be supported with the facts, that the so 
called “built in” alternative NO producing pathways were activated in 
all the investigated categories. The extent of the elevated NO demand 
can be deduced from the gradual activation of these pathways. In the 
high weight twin pairs with no obvious sign for ED, only the RBC-NOS3- 
NO pathway was activated, both at the translational and phosphoryla-
tion levels. In case of the lower weight twin pairs it is even more 
important to ensure the availability of rescue mechanisms. In addition to 
activation of the RBC-NOS3-NO pathway, an increased phosphorylation 
at the Ser1177 position was observed in both the arteries and the veins. 
Moreover, an inducible NOS isoform, the NOS2 was triggered in the 
arterial endothelium. NOS2 is induced under pathological conditions 
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Fig. 4. Viability assay on the isolated arterial cord RBCs derived from preterm non-discordant twin siblings. Representative zebra plots on isolated RBCs treated with 
FITC (Fluorescein IsoThioCyanate) - conjugated Annexin V of (A) premature high weight singleton (Hws), (B and C) premature high weight twin (Hwt) and (D) 
premature low weight twin (Lwt). Based on the blank value of the appropriate control and twin sample, an arbitrary borderline was considered along the x-axis, 
where the Q3 quadrant represents the Annexin V positive cells. The graphical summary (E) shows the percentage distribution of Annexin V positive RBCs localized in 
Q3 quadrant. **** marks the significant differences based on the Newman-Keuls multiple comparison test at p < 0.0001. 
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like inflammation, sepsis or oxidative stress [36], and even a moderate 
increase in its expression could sufficiently increase the NO level, 
regarding to the higher rate of NOS2 catalytic activity i.e. (100–1000 
fold that of the NOS3) [37,38]. As for the discordant population, in the 
lower weight siblings, both the activated RBC-NOS3-NO pathway and 
the upregulated arterial NOS2 system might be available as the 
compensatory mechanisms. 
At the first glance, extended NO production seems to be beneficial 
when there is an insufficient level of bioavailable NO in the vascular 
system, however, increased synthesis of NO may indicate to a higher 
degree of oxidative stress. Under severe oxidative stress conditions the 
increased level of O2•− through a spontaneous reaction with the 
bioavailable NO, instantaneously initiates the formation of ONOO− , 
which signifies the “Janus faced” feature of NO [39]. This assumption 
was clearly supported by our data on the viability assays that were 
performed with RBC populations, showing increased frequency of the 
Annexin V positive cells which indicated cell death by apoptosis and also 
further by the higher extent of the macromolecular damages as rein-
forced by the elevated formation of 4-HNE adducts. 
Studying the morphological variants in the twin RBC population, we 
exhibited a significant rise in the Burr cell population irrespective of 
birth weight and maturity. Losing their characteristic biconcave shape 
might be the consequences of both altered cytoskeletal network along 
with disproportional distribution of fatty acids, lysophospholipids in the 
RBC plasma membrane [40]. Furthermore, specifically in the preterm 
twin category we cited a significant distribution of Elliptocytes and 
Rouleaux phenotypes. Based on wide range of clinical studies morpho-
logical differentiation of Elliptocytes, indicated iron deficiency and 
megaloblastic anaemia whereas the formation of RBC aggregates, due to 
high fibrinogen level, results in lower blood flow rates that might lead to 
pathogenesis of circulatory and thromboembolic complications in clin-
ical cases like pregnancy, diabetes, etc. [41,42]. The increased level of 
phenotypic variations in the RBC populations could be a warning sign 
for their impaired functional and/or physiological properties, however, 
it is most likely that there is no apparent link between the varying 
morphological alteration and the RBC-NOS3 activation capacity. In our 
earlier study, we already provided evidence on elevated level of 
morphological variants in the fetal RBC populations exposed to toxic 
materials, due to maternal smoking [43]. In those cell populations the 
RBCs were functionally impaired far before their detectable 
Fig. 5. Viability Assay on the isolated arterial cord RBCs derived from the preterm discordant twin pairs. Panel (A–B) represents the zebra plots of the isolated 
arterial cord RBCs derived from preterm discordant twin pairs that are treated with FITC (Fluorescein IsoThioCyanate) - conjugated Annexin V. Based on the blank 
value of the appropriate control and twin sample, an arbitrary borderline was considered along the x-axis, where the Q3 quadrant represents the Annexin V positive 
cells. The graphical summary (C) shows the percentage distribution of Annexin V positive RBCs localized in Q3 quadrant. Statistical significance was accepted at 
****p < 0.0001 using the Newman-Keuls multiple comparison test. 
Fig. 6. Distribution of morphological variants of 
RBCs derived from mature and premature twin sib-
lings. Distribution of morphological variants in iso-
lated RBC from singletons in comparison to mature 
and premature twin populations. Screening of RBCs 
(N = 600 cells/sample groups) were counted from 
both singleton and twin origins. Statistical signifi-
cance in the frequencies of the regular Biconcave at 
(***p < 0.001), Burr at (***p < 0.001 and ****p <
0.0001), Elliptocytes at (****p < 0.0001 and **p <
0.01) and Rouleaux at (****p < 0.0001) were 
accepted by one-way ANOVA using the Newman- 
Keuls multiple comparison test. Sample number = 5 
from each groups.   
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morphological alterations. So we hypothesized that the NOS3 activation 
pathway was impaired independently from their phenotypical appear-
ance [43]. 
Comparing the pre-mature data set with the values experienced in 
mature twin samples [24], the most striking and distinct difference lies 
in the veins. In exception, to the low weight discordant neonates most 
likely there were no alterations in the venous NOS3 expression/activa-
tion of the pre-mature twin groups whereas, in both, the high and low 
weight mature twin populations a drastic decrease was observed in the 
vein endothelium. Possibly, it might be explained by the enhanced level 
of an adverse intrauterine environment during the progressive preg-
nancy period; where the uterus becomes highly expanded, the oxygen 
pressure greatly reduced and the materno-fetal oxygen transfer gets 
significantly lowered [44–46]. All these parameters together point out 
towards an elevated pre-placental hypoxia and as a result of hypoxia- 
induced ROS generation, a cascade of harmful processes appears [47]. 
One of the harmful consequences of the highly elevated ROS might 
induce the Arginase1 expression in the circulating RBCs, and as its 
sequel probably influences on the RBC-NOS3 regulatory pathway. 
Indeed, in the RBC populations of mature twins the Arginase1 level was 
double of the age and weight matched singletons. Moreover, higher level 
of Arginase1 not only affects the NOS3-NO pathway in the circulating 
RBCs, but also in the vessels' endothelium. In the mature twin popula-
tion, together with neonates born to smoking mothers the high Argi-
nase1 level was paralleled with increased ED, as a result of impairment 
of the NOS3-NO pathway in the UC vessels [24,43,48]. In line with this 
fact, Pernow and his co-workers previously presented the evidence of 
efficient cross-talk between the circulating RBCs and vessel endothe-
lium, where RBCs became the protagonist player in augmenting the 
formation of ED, through the Arginase-dependent regulation process 
[49,50]. 
5. Conclusion 
In this study we provided additional evidence for the active regula-
tory role of fetal RBCs in the rate of blood flow, by their increased 
expression/activation of NOS3 under hypoxic conditions. This data set, 
similarly to recent publication [51], also points out that independently, 
both the endothelial cells and RBCs are found to be important regulators 
and separately contribute to the NO metabolism, vascular function, 
systemic hemodynamics and blood pressure homeostasis via NOS3. 
Additionally, comparing our data set on premature twins (33–35 weeks) 
to our previous works [24,43], indicated that the NOS3-activation ca-
pacity of the cord vessels and fetal RBCs may be more efficient than in 
case of the mature twin population (37–39 weeks) or in neonates, born 
to smoking mothers. There had been a clear observation, that irre-
spectively of a common, highly hypoxic environment which character-
izes premature or mature twin pregnancies and maternal smoking 
induced conditions in the neonates, the mediated oxidative stress 
response varies based on the distinguishable level of Arginase1. The 
direct correlation between Arginase1 and NOS3 for their competition to 
the common substrate L-arginine becomes complicated with the 
emerging paradox that states L-arginine concentrations in endothelial 
cells remain sufficiently high to support NO synthesis on the approach of 
compartmentalization of intracellular L-arginine into distinct, poorly 
interchangeable pools [52]. However, apart from other cell types, RBCs 
hold a unique cytoskeletal structure and are devoid of major intracel-
lular organelles where the chances of intracellular L-arginine compart-
mentalization into distinct interchangeable pools become negligible. 
Hence we supposed that Arginase1 dependent alterations in the RBC- 
NOS pathway seem to be a determining factor for the further develop-
ment of ED in the vascular system. 
Furthermore, the understanding of NOS3 signalling at different time 
points of gestation also seemed to be essential from the clinical purview, 
due to rapid changes in the mechanisms, during the progressive preg-
nancy period. 
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M. Feelisch, M. Kelm, Human red blood cells at work: identification and 
visualization of erythrocytic eNOS activity in health and disease, Blood. 120 
(2012) 4229–4237, https://doi.org/10.1182/blood-2012-07-442277. 
[28] P. Chakraborty, K.N. Dugmonits, A.G. Végh, R. Hollandi, P. Horváth, J. Maléth, 
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